Roche to present new obesity data at ADA 2026 Scientific Sessions Late-stage data highlight efficacy and safety of investigational therapies enicepatide and petrelintide for weight management 5 Jun 2026 Roche will present new Phase II data from its obesity portfolio, including the investigational medicines enicepatide (CT-388) and petrelintide, at the American Diabetes Association (ADA) 2026 Scientific Sessions in the United States
1Up Nutrition Natural Vegan BCAA + Glutamine, Mango Lime - 360g MRP: 11,397.00 Price: 8,767.00 Muscle recovery, lean Muscle growth, protein synthesis, performance & strength
Phase 3 SURMOUNT trials demonstrated average weight loss of 22% over 68 weeks in the highest dose group, with significant loss occurring by week 12-16
Comprehensive Weight Loss Support in Pinehurst We provide a full range of services to ensure your success: GLP-1 Medications : Semaglutide and Tirzepatide for proven results
Xut x: Balan
Genetics: Variations in melanin levels are studied to understand genetic diversity and adaptation
